China · Delayed Price · Currency is CNY Runben Biotechnology Statistics
Total Valuation
SHA:603193 has a market cap or net worth of CNY 8.19 billion. The enterprise value is 6.68 billion.
| Market Cap | 8.19B |
| Enterprise Value | 6.68B |
Important Dates
The next confirmed earnings date is Friday, October 23, 2026.
| Earnings Date | Oct 23, 2026 |
| Ex-Dividend Date | Sep 21, 2026 |
Share Statistics
SHA:603193 has 404.59 million shares outstanding. The number of shares has decreased by -1.12% in one year.
| Current Share Class | 404.59M |
| Shares Outstanding | 404.59M |
| Shares Change (YoY) | -1.12% |
| Shares Change (QoQ) | -1.45% |
| Owned by Insiders (%) | 29.19% |
| Owned by Institutions (%) | 2.80% |
| Float | 82.23M |
Valuation Ratios
The trailing PE ratio is 23.03 and the forward PE ratio is 21.77.
| PE Ratio | 23.03 |
| Forward PE | 21.77 |
| PS Ratio | 4.81 |
| PB Ratio | 3.50 |
| P/TBV Ratio | 3.63 |
| P/FCF Ratio | 32.97 |
| P/OCF Ratio | 24.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.11, with an EV/FCF ratio of 26.90.
| EV / Earnings | 18.98 |
| EV / Sales | 3.92 |
| EV / EBITDA | 17.11 |
| EV / EBIT | 18.15 |
| EV / FCF | 26.90 |
Financial Position
The company has a current ratio of 8.74, with a Debt / Equity ratio of 0.00.
| Current Ratio | 8.74 |
| Quick Ratio | 7.84 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.00 |
| Interest Coverage | 6,648.94 |
Financial Efficiency
Return on equity (ROE) is 15.59% and return on invested capital (ROIC) is 32.87%.
| Return on Equity (ROE) | 15.59% |
| Return on Assets (ROA) | 9.42% |
| Return on Invested Capital (ROIC) | 32.87% |
| Return on Capital Employed (ROCE) | 15.71% |
| Weighted Average Cost of Capital (WACC) | 5.25% |
| Revenue Per Employee | 1.67M |
| Profits Per Employee | 345,842 |
| Employee Count | 1,018 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 4.68 |
Taxes
In the past 12 months, SHA:603193 has paid 49.64 million in taxes.
| Income Tax | 49.64M |
| Effective Tax Rate | 12.36% |
Stock Price Statistics
The stock price has decreased by -29.02% in the last 52 weeks. The beta is 0.18, so SHA:603193's price volatility has been lower than the market average.
| Beta (5Y) | 0.18 |
| 52-Week Price Change | -29.02% |
| 50-Day Moving Average | 20.71 |
| 200-Day Moving Average | 22.47 |
| Relative Strength Index (RSI) | 48.06 |
| Average Volume (20 Days) | 2,584,730 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603193 had revenue of CNY 1.70 billion and earned 352.07 million in profits. Earnings per share was 0.88.
| Revenue | 1.70B |
| Gross Profit | 1.02B |
| Operating Income | 368.31M |
| Pretax Income | 401.70M |
| Net Income | 352.07M |
| EBITDA | 389.28M |
| EBIT | 368.31M |
| Earnings Per Share (EPS) | 0.88 |
Balance Sheet
The company has 1.51 billion in cash and 704,850 in debt, with a net cash position of 1.51 billion or 3.73 per share.
| Cash & Cash Equivalents | 1.51B |
| Total Debt | 704,850 |
| Net Cash | 1.51B |
| Net Cash Per Share | 3.73 |
| Equity (Book Value) | 2.34B |
| Book Value Per Share | 5.79 |
| Working Capital | 1.59B |
Cash Flow
In the last 12 months, operating cash flow was 330.45 million and capital expenditures -81.96 million, giving a free cash flow of 248.49 million.
| Operating Cash Flow | 330.45M |
| Capital Expenditures | -81.96M |
| Depreciation & Amortization | 20.97M |
| Net Borrowing | -1.52M |
| Free Cash Flow | 248.49M |
| FCF Per Share | 0.61 |
Margins
Gross margin is 59.63%, with operating and profit margins of 21.62% and 20.67%.
| Gross Margin | 59.63% |
| Operating Margin | 21.62% |
| Pretax Margin | 23.58% |
| Profit Margin | 20.67% |
| EBITDA Margin | 22.85% |
| EBIT Margin | 21.62% |
| FCF Margin | 14.59% |
Dividends & Yields
This stock pays an annual dividend of 0.54, which amounts to a dividend yield of 2.67%.
| Dividend Per Share | 0.54 |
| Dividend Yield | 2.67% |
| Dividend Growth (YoY) | 25.58% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 51.94% |
| FCF Payout Ratio | 87.92% |
| Buyback Yield | 1.12% |
| Shareholder Yield | 3.79% |
| Earnings Yield | 4.30% |
| FCF Yield | 3.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SHA:603193 is 31.18, which is 53.98% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 31.18 |
| Price Target Difference | 53.98% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 18.17% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603193 has an Altman Z-Score of 32.4 and a Piotroski F-Score of 5.
| Altman Z-Score | 32.4 |
| Piotroski F-Score | 5 |